Cronos Group Inc. (CRON.TO)
CAD 2.53
(2.02%)
CAD 2.53
(2.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -84.8 Million USD | 26.9% |
| 2022 | -116.01 Million USD | -1809.83% |
| 2021 | 6.78 Million USD | 103.78% |
| 2020 | -179.34 Million USD | -47.63% |
| 2019 | -121.48 Million CAD | -813.77% |
| 2018 | -13.29 Million CAD | -693.09% |
| 2017 | -1.67 Million CAD | -36.83% |
| 2016 | -1.22 Million CAD | -326.74% |
| 2015 | 540.33 Thousand CAD | 117.56% |
| 2014 | -3.07 Million CAD | -396.63% |
| 2013 | -619.47 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -15.56 Million USD | 2.43% |
| 2024 Q1 | -15.94 Million USD | 26.29% |
| 2023 Q1 | -21.99 Million USD | 25.99% |
| 2023 FY | -84.8 Million USD | 26.9% |
| 2023 Q4 | -21.63 Million USD | 0.64% |
| 2023 Q3 | -21.77 Million USD | -5.6% |
| 2023 Q2 | -20.62 Million USD | 6.26% |
| 2022 Q2 | -26.79 Million USD | 9.08% |
| 2022 FY | -116.01 Million USD | -1809.83% |
| 2022 Q1 | -29.47 Million USD | 81.88% |
| 2022 Q4 | -29.71 Million USD | 2.5% |
| 2022 Q3 | -30.48 Million USD | -13.75% |
| 2021 Q4 | -162.63 Million USD | -188.29% |
| 2021 Q1 | -43.45 Million USD | 25.6% |
| 2021 FY | 6.78 Million USD | 103.78% |
| 2021 Q3 | -56.41 Million USD | 6.32% |
| 2021 Q2 | -60.21 Million USD | -38.56% |
| 2020 Q2 | -34.75 Million USD | 22.87% |
| 2020 Q1 | -45.06 Million USD | 29.45% |
| 2020 Q4 | -58.41 Million USD | -41.88% |
| 2020 Q3 | -41.16 Million USD | -18.45% |
| 2020 FY | -179.34 Million USD | -47.63% |
| 2019 Q3 | -40.91 Million CAD | -164.01% |
| 2019 FY | -121.48 Million CAD | -813.77% |
| 2019 Q4 | -63.86 Million CAD | -56.11% |
| 2019 Q2 | -15.49 Million CAD | -3608.27% |
| 2019 Q1 | -417.91 Thousand CAD | 94.91% |
| 2018 Q1 | -1.68 Million CAD | -1119.75% |
| 2018 Q4 | -8.21 Million CAD | -117.59% |
| 2018 FY | -13.29 Million CAD | -693.09% |
| 2018 Q3 | -3.77 Million CAD | -1113.17% |
| 2018 Q2 | 372.56 Thousand CAD | 122.09% |
| 2017 Q3 | -31.04 Thousand CAD | 98.74% |
| 2017 FY | -1.67 Million CAD | -36.83% |
| 2017 Q4 | 165.38 Thousand CAD | 632.73% |
| 2017 Q2 | -2.46 Million CAD | -217.01% |
| 2017 Q1 | -776.01 Thousand CAD | -155.94% |
| 2016 Q1 | -373.55 Thousand CAD | -115.91% |
| 2016 FY | -1.22 Million CAD | -326.74% |
| 2016 Q4 | 1.38 Million CAD | 621.43% |
| 2016 Q3 | -266.05 Thousand CAD | 85.71% |
| 2016 Q2 | -1.86 Million CAD | -398.33% |
| 2015 Q2 | -556.79 Thousand CAD | 26.5% |
| 2015 FY | 540.33 Thousand CAD | 117.56% |
| 2015 Q4 | 2.34 Million CAD | 575.95% |
| 2015 Q3 | -493.33 Thousand CAD | 11.4% |
| 2015 Q1 | -757.54 Thousand CAD | 0.0% |
| 2014 FY | -3.07 Million CAD | -396.63% |
| 2014 Q3 | -76.68 Thousand CAD | -647.61% |
| 2014 Q2 | -10.25 Thousand CAD | 0.0% |
| 2013 FY | -619.47 Thousand CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -46.45 Million CAD | -82.55% |
| Avicanna Inc. | -7.93 Million CAD | -968.951% |
| Avant Brands Inc. | -1.45 Million CAD | -5744.245% |
| Cardiol Therapeutics Inc. | -29.78 Million CAD | -184.702% |
| Crescita Therapeutics Inc. | -1.95 Million CAD | -4235.378% |
| Knight Therapeutics Inc. | -2.89 Million CAD | -2834.256% |
| MediPharm Labs Corp. | -18.25 Million CAD | -364.607% |
| OrganiGram Holdings Inc. | -242.73 Million CAD | 65.065% |
| Canopy Growth Corporation | -228.71 Million CAD | 62.923% |
| Willow Biosciences Inc. | -13.18 Million CAD | -543.301% |
| Auxly Cannabis Group Inc. | -19 Million CAD | -346.198% |